Streetbeat News

Analyst Ratings

KVUE

A whale investor has taken a bullish stance on Kenvue (NYSE:KVUE), with 66% of the investors opening trades with bullish expectations and 33% with bearish. The whale has been targeting a price range from $19.0 to $22.5 for Kenvue over the last 3 months. The price of KVUE is currently down -0.38% at $21.0. The next earnings are expected to be released in 50 days.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:31 pm

GIS

A significant number of bullish trades have been observed in General Mills's (NYSE:GIS) options, with 78% of investors opening trades with bullish expectations. The majority of the trades are calls, amounting to $1,708,231, while puts total $70,000. Whales have been targeting a price range from $55.0 to $70.0 for General Mills over the last 3 months. The current price of GIS is $65.89, down by 0.31%. Analysts from Wells Fargo, Piper Sandler, Deutsche Bank, JP Morgan, and TD Cowen have maintained their ratings on General Mills, with price targets ranging from $70 to $77.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:16 pm

KO

A whale investor has taken a bearish stance on Coca-Cola (NYSE:KO), with 69% of the spotted trades being bearish. The trades include 3 puts amounting to $113,970 and 10 calls amounting to $401,265. The targeted price range for Coca-Cola over the last 3 months is from $45.0 to $65.0. The current price of KO is up 0.13% at $58.38, with RSI indicators suggesting it may be approaching oversold.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:00 pm

GLOB

In the last quarter, Globant (NYSE:GLOB) received 11 analyst ratings, with 2 being bullish and 9 somewhat bullish. The company has an average 12-month price target of $217.0, which has increased by 9.71% over the past month.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:00 pm

HPK

Four analysts have provided ratings for HighPeak Energy (NASDAQ:HPK) in the last quarter, with one being bullish and three bearish. The average price target is $13.55, which is lower than the current price of $16.755, implying a downside. This average has decreased by 7.32% from the previous average price target of $14.62.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:00 pm

COOP

Mr. Cooper Gr (NASDAQ:COOP) has received mixed analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 1 indifferent. The average price target is $65.5, indicating potential upside from the current price of $54.12. This average has increased by 13.91% from the previous target of $57.50.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:00 pm

ACRS

Analysts have provided bullish ratings for Aclaris Therapeutics (NASDAQ:ACRS) within the last quarter, with an average price target of $36.0 versus the current price of $7.39. This average price target has increased by 125.0% over the past month.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 7:00 pm

NKE

A whale investor has taken a bullish stance on Nike (NYSE:NKE), with 69% of investors opening trades with bullish expectations and 30% with bearish. The whale has been targeting a price range from $85.0 to $105.0 for Nike over the last 3 months. The price of NKE is currently down -0.69% at $94.85, and RSI indicators suggest the stock may be approaching oversold. Nike's next earnings are expected to be released in 9 days.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 6:46 pm

SGEN

A significant bullish stance has been taken on Seagen (NASDAQ:SGEN) by an unknown entity, possibly an institution or a wealthy individual. This was noticed through publicly available options history. The overall sentiment of these big-money traders is split between 50% bullish and 50% bearish. The whales have been targeting a price range from $200.0 to $220.0 for Seagen over the last 3 months.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 6:46 pm

DXCM

Unusual options activity has been observed for DexCom (NASDAQ:DXCM), with a large position indicating a bullish stance. The options scanner at Benzinga spotted 12 uncommon trades, split 50% bullish and 50% bearish. The trades included 2 puts amounting to $99,460 and 10 calls amounting to $1,020,352. The targeted price range for DexCom over the last 3 months has been $85.0 to $130.0. The current price of DXCM is down -1.05% at $94.29. Analysts from UBS, Baird, and Raymond James have maintained their positive ratings on DexCom.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 6:45 pm